GL1X · GenesisL1 explorer

MolNFT v1 · #127953 · protein

Crystal structure of native alpha-1-antitrypsin with seven stabilising mutations

5NBV: “Crystal structure of native alpha-1-antitrypsin with seven stabilising mutations”. X-ray diffraction, 4 pockets (best druggability 0.54). MolNFT v1 #127953 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
5NBV
Type
protein
Length
369 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Alpha-1-antitrypsin
UniProt
P01009
Pockets
4 · best druggability 0.54

Structure

x-ray diffraction · 1 distinct chain · 29% helix, 30% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AAlpha-1-antitrypsinprotein36929% helix, 30% strandP01009

Ligands and binding sites

  • GOL · Glycerol · additive · 3 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1600.540.8821empty
2520.440.8314GOL
3590.310.7616empty
4550.300.7514empty

Compared structures

  • 5NBV · Crystal structure of native alpha-1-antitrypsin with seven stabilising mutations · the same entry in another collection · chain A against A, TM-score 1.00
  • P01009 · AlphaFold monomer V2.0 prediction for alpha-1-antitrypsin (P01009) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.